Shigeki Nanjo

5PUBLICATIONS
72CO-AUTHORS
Molecular targetsCancer diagnosisMechanobiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 02, 2026
Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

|May 28, 2024
Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis.

Tej D Azad, Shigeki Nanjo, Michael C Jin

|May 03, 2024
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer.

Franziska Haderk, Yu-Ting Chou, Lauren Cech

|Dec 04, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.

Deborah R Caswell, Philippe Gui, Manasi K Mayekar

|Jan 22, 2021
Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts.

Jeffrey J Quinn, Matthew G Jones, Ross A Okimoto

Pageof 1

Frequent Collaborators

4 joint publications

Trever G Bivona

2 joint publications

Wei Wu

2 joint publications

Ross Okimoto

2 joint publications

Lauren Cech